CD8A and neoplasm: CD8+ T cells in the tumor compartment was associated with better prognosis in terms of OS (HR 0.78; 0.66–0.93) and DSS (HR 0.69; 0.50–0.96) but not for DFS (HR 0.58; 0.32–1.04) or RFS (HR 1.22; 0.82–1.83).